VC in China
VC in China
• 2018: China’s VC market should exceed the US and - Investors coming off the
therefore dominate the world in 2019/2020... ‘burning money
2016:
- 275
2018:
- 975
2019:
- 163
1. E-commerce
2. Business services
·
·
Most of VCs are focusing on cutting edge technology:
Enterprise Services:
- AI
- New materials
-
-
Green technology
Smart manufacturing
5%
- Industrial robotics were frequently mentioned Only
- Sciences and biotechnology.
Amphivena Therapeutics
Amphivena Therapeutics, a subsidiary of Affimed Therapeutics, develops
treatments to address hematologic malignancies.
Total Funding Amount: USD$ 62M
Yunyinggu
Yunyinggu is a Chinese company dedicated to developing and promoting
new display technologies.
Total Funding Amount: CN¥157.5M
Zhuangxiaomi
Mioji Travel Ofo Hi Shop
(real estate company)
Total Funding Amount: Total Funding Amount: Total Funding Amount:
Total Funding Amount:
USD$ 6M CN¥15M USD$ 14M
CN¥ 2.3B
Industrial
TMT Healthcare Consumer/Service
Technology
- GGV was established nearly two decades ago in Singapore and Silicon
Valley
- Invested in Alibaba, Grab, TikTok, Youku-Tudou and more.
- Quickly established themselves as a global firm with five offices
around the world.
- Today GGV is expanding their global footprint with investment
roadmaps across the US, Latin America, Israel, Southeast Asia, China
and India, growing to manage 13 funds with over $6.2 billion AUM
(with $5bn raised this decade).
Mogulinker Technology
Mogulinker Technology is a domestic SaaS software provider specializing
in the post industrial equipment market.
Total Funding Amount: USD$ 3M
Ehang
Ehang is a technology enterprise focused on R&D and production in airplane and
aircraft field.
Total Funding Amount: USD$ 40M
Didi Chuxing
- Mobile transportation platform, offering a full range of
commuting options to 400 cities in China
- Raised about US$13.8 Bn to date
- Deal with Toyota Motor Corporation involved a JV to provide
vehicle-related services to drivers on DIdi’s ride sharing platform
- Biggest Investor: China Merchants Bank
JD Health
- E-Commerce Platform for Pharmaceutical Products
- Subsidiary of e-commerce giant JD.com
- Ranked the most valuable among 22 new unicorns in 2019
- Market size of China’s online healthcare industry: ~RMB 20.4 BN
(~ US$3Bn) in 2019 (iResearch)
- Completed a US$1 Bn funding round in November 2019, at a
US$7 Bn post-money valuation
- Investors include: CPE China Fund, CICC Capital
Ofo
- “Station-Free” Bike-sharing platform
- Dockless system uses an app to unlock & locate nearby bicycles,
charging an hourly rate for use
- Deployed over 10mm bicycles in 250 cities & 20 countries
- Company was valued at up to US$2 bn, with over 62.7 mm
monthly active users
- In 2018, Ofo announced massive reduction in operations,
including withdrawing from several countries like US and SG
- Declared Bankruptcy in December 2018
● The amount of investments going into China shows investors’ confidence in the Chinese Start-Up
industry BUT
○ Even if investors are encouraged by the Chinese market as well as the ideas provided by these
companies, it is important for investors to have a clear matrix and to understand their risk
tolerance when evaluating investment decisions
● Ultimately, what everyone wants to have investments like Didi and JD, and not Ofo.